See every side of every news story
Published loading...Updated

Now You Don’t Need Reading Glasses, New FDA-Approved Eye Drops Can Sharpen Near Vision

The US Food and Drug Administration has approved Vizz eye drops. These drops improve near vision for adults over 40. Lenz Therapeutics developed this aceclidine-based treatment. Vizz narrows the pupil, increasing focus. Clinical trials showed results within 30 minutes, lasting up to 10 hours. Common side effects include dim vision and eye irritation.

10 Articles

Lean Left

The drug is the only eye drops administered daily that correct vision for 10 hours

·Buenos Aires, Argentina
Read Full Article
Center

The administration of Food and Medicines (FDA) in the United States has, on a global scale, approved ophthalmic doses based on aceclidine for prebiotic treatment, an infection affecting almost all adults after 45 years of age.

·Romania
Read Full Article

The Food and Drug Administration of the United States, FDA, authorized the marketing and use of the first eye drops to solve the problems caused by the presbyopia. The drug allows, for about 10 hours, to see closely without having to use eyes atoe. The commercial name of the new product is Vizz, and it is the only eye drops of daily use that corrects vision for 10 hours. Presbyopia appears in humans when the eyes gradually lose the ability to se…

The U.S. Food and Drug Administration (FDA) has approved VIZZ, an eye drop that promises to forever change the way we treat presbyopia (which can't be prevented but is increasingly easy to detect). Developed by LENZ Therapeutics, this innovative treatment is presented as a real alternative for those who don't want to rely on glasses or contact lenses for reading or close-up work. Read more]]>

The U.S. Food and Drug Administration (FDA) has approved the use of a few eye drops with aceclidin from the pharmaceutical company Lenz to treat presbysis, also known as tired vision. This visual defect, associated with age, makes it difficult to focus near objects and affects millions of people around the world. It is a compound used in Europe since the 1970s for the treatment of glaucoma. Its action consists of gently contracting iris, generat…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Libertad Digital broke the news in on Friday, August 8, 2025.
Sources are mostly out of (0)

Similar News Topics